Our work: details

One of the possible effects of chemotherapy is the suppression of the immune system. As a result, even a mild illness can put patients at risk of developing a condition called neutropenic sepsis (NS), a life-threatening medical emergency. If patients have any signs of an infection, they have to be rapidly brought to hospital to undergo a blood test. While the healthcare team awaits results for 1-2 hours, the patient is given intravenous antibiotics as a precaution, because delays to treatment increase the risk of death. However, around 50% of these patients brought into hospital turn out not to have NS – and therefore did not need to attend hospital or have antibiotics.
 
At Neutrocheck we want to give patients back some peace of mind. To achieve this, we are developing a fast, reliable and low-cost device to test for NS symptoms at home, improving patient safety and quality of life, reducing antibiotic wastage, and empowering doctors to treat their patients efficiently.

For patients, Neutrocheck has the potential to 

  • Reduce mortality risk

  • Reduce the number of trips to hospital

  • Provide peace of mind

  • Reduce antibiotic resistance

For nurses and doctors, Neutrocheck has the potential to

  • Aid triaging decisions

  • Reduce case-load in emergency rooms

  • Reduce patient mortality

  • Reduce antibiotic resistance

For providers, Neutrocheck has the potential to

  • Free-up emergency room and acute resources

  • Reduce costs

  • Improve patient outcomes

  • Reduce antibiotic resistance

For payers, Neutrocheck has the potential to

  • Reduce costs

  • Improve patient outcomes

  • Reduce antibiotic resistance

If you would like to learn more about Neutrocheck, contact us.

Contact

Head Office

ideaSpace Addenbrooke's

Cambridge CB2 0AH

© 2020 Neutrocheck Ltd